{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T10:13:03Z","timestamp":1775211183632,"version":"3.50.1"},"reference-count":38,"publisher":"Informa Healthcare","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2010,2,1]]},"DOI":"10.1185\/03007990903482772","type":"journal-article","created":{"date-parts":[[2009,12,10]],"date-time":"2009-12-10T15:28:57Z","timestamp":1260458937000},"page":"377-387","source":"Crossref","is-referenced-by-count":61,"title":["Practical guidance for dosing and switching paliperidone palmitate treatment in patients with schizophrenia"],"prefix":"10.1185","volume":"26","author":[{"given":"S.","family":"Gopal","sequence":"first","affiliation":[{"name":"Johnson & Johnson PRD, LLC, Titusville, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gassmann-Mayer","sequence":"additional","affiliation":[{"name":"Johnson & Johnson PRD, LLC, Titusville, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Palumbo","sequence":"additional","affiliation":[{"name":"Johnson & Johnson PRD, LLC, Titusville, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.N.","family":"Samtani","sequence":"additional","affiliation":[{"name":"Johnson & Johnson PRD, LLC, Raritan, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Shiwach","sequence":"additional","affiliation":[{"name":"DeSoto, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Alphs","sequence":"additional","affiliation":[{"name":"Ortho-McNeil Janssen Scientific Affairs, LLC, Titusville, NJ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2009,12,10]]},"reference":[{"issue":"4","key":"CIT0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1176\/ajp.154.4.1","volume":"154","author":"American Psychiatric Association","year":"1997","journal-title":"Am J Psychiatry"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91325-4"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n1105"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2006.00982.x"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.01.017"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2006.09.012"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.03.003"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.2165\/11316870-000000000-00000"},{"key":"CIT0009","unstructured":"Paliperidone palmitate Prescribing Information 2009. Available at: http:\/\/www.invegasustenna.com\/invegasustenna\/shared\/pi\/invegasustenna.pdf. Accessed November 2009"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1208\/aapsj070351"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100051"},{"key":"CIT0012","unstructured":"Tornoe CW, Bhattaram V, Earp JC, et al. Impact of pharmacometric reviews on new drug approval and labeling decisions \u2013 a survey of 65 NDAs Between 2006 and 2008. American Conference on Pharmacometrics, Mashantucket, CT, USA, Oct 4\u20137 2009. Poster no. S1"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.430330403"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1007\/BF02245606"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.018275"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1002\/hup.1049"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.11.006"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.11.006"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2007.11.006"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2009.05.014"},{"key":"CIT0021","unstructured":"Pandina G, Lindenmayer JO, Lull J. A randomized, double-blind, placebo-controlled, dose\u2013response study to assess efficacy and safety of paliperidone palmitate in adult subjects with schizophrenia. Annual Meeting of the International Congress of Schizophrenia Research, San Diego, CA, USA, March 28 \u2013 April 2009. Poster no. 31"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n1104"},{"key":"CIT0023","unstructured":"Samtani MN, Kern-Sliwa J, Haskins JT. Initiation dosing of deltoid intramuscular paliperidone palmitate in schizophrenia: pharmacokinetic rationale based on modeling and simulation. Annual Meeting of the College of Psychiatric and Neurologic Pharmacists, Jacksonville, FL, USA, April 19\u201322, 2009. Poster no. 19"},{"key":"CIT0024","unstructured":"Samtani MN, Kern-Sliwa J, Haskins JT, et al. Initiation dosing of deltoid intramuscular paliperidone palmitate in schizophrenia: pharmacokinetic rationale based on modeling and simulation. Annual Meeting of the American Psychiatric Association, San Francisco, CA, USA, May 16\u201321 2009. Poster no. NRI-046"},{"key":"CIT0025","unstructured":"Samtani MN, Haskins JT, Alphs S, et al. Maintenance dosing of once-monthly (4-weekly) paliperidone palmitate in schizophrenia: pharmacokinetic rationale based on population simulations. Annual Meeting of the College of Psychiatric and Neurologic Pharmacists, Jacksonville, FL, USA, 19\u201322 April 2009. Poster no. 21"},{"key":"CIT0026","unstructured":"Samtani MN, Gopal S, Kern Sliwa J, et al. Switching to paliperidone palmitate from other antipsychotics: guidance based on pharmacokinetic modeling and simulations. New Clinical Drug Evaluation Unit, Hollywood, FL, USA, Jun 29 \u2013 Jul 2 2009. Poster no. I-68"},{"key":"CIT0027","unstructured":"Samtani MN, Gopal S, Kern Sliwa J, et al. Management of missed paliperidone palmitate doses based on pharmacokinetic modeling and simulation. New Clinical Drug Evaluation Unit, Hollywood, FL, USA, 29 Jun \u2013 2 Jul 2009. Poster no. II-62"},{"key":"CIT0028","unstructured":"Fleischhacker WW, Gopal S, Samtani MN, et al. Optimization of the dosing strategy for the long-acting injectable antipsychotic paliperidone palmitate: results of two randomized double-blind studies and population pharmacokinetic simulations. Annual Meeting of the American College of Neuropsychopharmacology, Scottsdale, AZ, USA, Dec 7\u201311 2008. Poster no. 21"},{"issue":"1","key":"CIT0029","first-page":"85","volume":"81","author":"Karlsson P","year":"2006","journal-title":"Schizophrenia Res"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.153.7.948"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(93)90288-O"},{"issue":"3","key":"CIT0032","first-page":"81","volume":"10","author":"Nyberg S","year":"1995","journal-title":"Int Clin Psychopharmacol"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(97)00045-X"},{"key":"CIT0034","unstructured":"Samtani MN, Haskins JT, Alphs L, et al. Maintenance dosing of once-monthly (4-weekly) paliperidone palmitate in schizophrenia: pharmacokinetic rationale based on population simulations. Annual Meeting of the American Psychiatric Association 2009: San Francisco, CA, USA, May 16\u201321, 2009. Poster no. NRI-036"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100044"},{"key":"CIT0036","unstructured":"Cleton A, Rossenu S, Hough D, et al. Assessment of the dose proportionality of paliperidone palmitate, a long-acting injectable antipsychotic, following deltoid or gluteal administration. Annual Meeting of the Institute of Psychiatric Services, Chicago, IL, USA, October 2\u20135, 2008. Poster no. 59"},{"issue":"15","key":"CIT0037","first-page":"16","volume":"55","author":"Centers for Disease Control and Prevention","year":"2006","journal-title":"MMWR"},{"key":"CIT0038","first-page":"1709","volume":"277","author":"Poland GA","year":"1997","journal-title":"Implications for needle length in adult immunization. JAMA"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/03007990903482772","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T11:13:06Z","timestamp":1599304386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/03007990903482772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,10]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2,1]]}},"alternative-id":["10.1185\/03007990903482772"],"URL":"https:\/\/doi.org\/10.1185\/03007990903482772","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,10]]}}}